A newest research shows Canadian researcher, what will be used at treating metabolic disorder disease for years is cheap acerbity salt of 2 chloric second can kill medicaments a variety of cancer cell.
A newest research shows Canadian researcher, what will be used at treating metabolic disorder disease for years is cheap acerbity salt of 2 chloric second can kill medicaments a variety of cancer cell.
According to England of newest first phase " new scientist " magazine story, all sorts of cells undertook the human body that the researcher of Canadian Ai Baida university uses this kind of medicaments to be fostered to be outside body check, discover it can kill cancer of lung cancer, breast and cerebral cancer cell, but did not damage to healthy cell.
Report, researcher also confirmed this one conclusion to the experiment of experimental rat. Researcher gives experimental rat inject cancer cell, make its tumor grows inside body, next number week is fed to them feed the water that adds acerbity salt of 2 chloric second, the result discovers the tumour inside experimental mouse system narrowed apparently.
Heretofore, people thinks all the time, suffer as a result of line bead body of the cell cannot the attaint of repair, canceration cell uses candy ferment to solve generation lactic acid, destroy the collagen matrix that makes the cell assembles together, such canceration cells can get releasing, flow direction human body is other place, form new tumour. But the experiment of Canadian researcher makes clear, the circumstance is not beyond recall, the line bead body in can waking up cancer cell once more because of acerbity salt of 2 chloric second, activation cell wither dies mechanism, make canceration cell die.
Researcher says, acerbity salt of 2 chloric second may pose the problem such as aching, coma to a few patients, but if it has the effect to treating a lot of cancer, taking the price that place of this kind of medicaments pays perhaps is worthiness. Researcher plans to use acerbity salt of 2 chloric second to have clinical trial to cancer patient next.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment